Clinical trials: Endotoxemia
Obesity, Hyperglycemia
The Effect of a Bifidobacterium and Polydextrose on Body Fat Mass
Obesity is a major problem worldwide, and it is related to abnormalities in glucose and lipid metabolism. The purpose of this study is to investigate the effect of a dietary supplement containing probiotic (Bifidobacterium…
- Conditions
- Obesity, Hyperglycemia, Insulin Resistance
- Trial name
- MetSProb (NCT01978691)
- Testing
- Bifidobacterium animalis ssp. lactis 420, Polydextrose
- Where
- 4 sites in Finland
- Volunteers
- 225 people, healthy volunteers welcome
- Sponsor
- Danisco
Anemia of Chronic Disease
Pharmacokinetics/Pharmacodynamics of NOX-H94 in the Human Endotoxemia Model
The purpose of this study is to assess the effect of the anti-hepcidin Spiegelmer NOX-H94 on iron homeostasis during systemic inflammation induced by endotoxin.
- Trial name
- NCT01522794
- Testing
- NOX-H94
- Where
- Netherlands
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- TME Pharma AG
Metabolic Endotoxemia, Metabolic Syndrome
Probiotics and Endotoxemia
The purpose of this study is to determine whether probiotic treatment of overweight volunteers consuming high fat diet is able to reduce plasma lipopolysaccharide concentration.
- Trial name
- PROMS-01 (NCT01176942)
- Testing
- Probiotic bacterium Bifidobacterium lactis
- Where
- France
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- Danisco
Healthy Volunteers
Adrecizumab-LPS Study
In this randomized, double-blind, placebo-controlled study, either a single dose of Adrecizumab (0.5, 2.0 or 8.0 mg/kg) or placebo will be administrated to 24 healthy male volunteers during experimental endotoxemia.
- Trial name
- NCT03083171
- Testing
- Endotoxin, Adrecizumab
- Where
- Netherlands
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Adrenomed AG